Regular blood sugar checks throughout the day and timely insulin shots are not an easy task, even for a disciplined diabetic. What to say about those cases when the patient who needs them is a small child.
But the situation may change soon. The US Food and Drug Administration (FDA) has just approved a device that drastically simplifies the process. The Medtronic MiniMed 770G system can now be used independently by children 2 to 6 years old with type 1 diabetes.
The MiniMed 770G contains a body-mounted sensor that reads your blood sugar every five minutes. The kit also includes a small pump and an infusion patch with an insulin delivery catheter. The system automatically regulates the level of the incoming hormone - the carrier does not have to perform any special actions. Technically, the MiniMed 770G has only two limitations - the parents of the child must still give him insulin after meals and the device cannot be used on children under two years old.
The MiniMed 770G system was rigorously tested on 46 children with type 1 diabetes for three months before being approved by the FDA. But despite being licensed by the FDA, Medtronic is still working on it. The company now needs to conduct extensive post-market research to evaluate the MiniMed 770G's performance under real-world conditions.